Endothelial function fluctuates with diurnal variation in the frequency of ischemic episodes in patients with variant angina  by Kawano, Hiroaki et al.
Endothelial Function Fluctuates With
Diurnal Variation in the Frequency of
Ischemic Episodes in Patients With Variant Angina
Hiroaki Kawano, MD, PHD,* Takeshi Motoyama, MD, PHD,* Hirofumi Yasue, MD, PHD,†
Nobutaka Hirai, MD,* Hesham M. Waly, MD, PHD,§ Kiyotaka Kugiyama, MD, PHD,‡
Hisao Ogawa, MD, PhD*
Kumamoto and Kohfu, Japan; and Mansoura, Egypt
OBJECTIVES The aim of the present study was to investigate whether there is diurnal fluctuation in the
endothelial function of patients with variant angina (VA).
BACKGROUND Coronary spasm is induced by acetylcholine and is promptly relieved by nitroglycerin. Thus,
it is possible that endothelial dysfunction is involved in the pathogenesis of coronary spasm.
Furthermore, the frequency of ischemic episodes is known to display diurnal variation.
METHODS Flow-mediated, endothelium-dependent vasodilation of the brachial arteries was measured in
the early morning (6 AM), afternoon (2 PM) and evening (8 PM) in 20 patients with VA (mean
age 54.5 years; 10 men and 10 women) and in 20 control subjects (mean age 54.2 years; 10
men and 10 women). All patients underwent 24-h ambulatory electrocardiographic moni-
toring during the study.
RESULTS Flow-mediated vasodilation in patients with VA was deteriorated by the early morning and
improved by the afternoon (patients with VA at 8 PM vs. 6 AM vs. 2 PM: 7.8 2.1% (p 0.01
vs. VA at 6 AM) vs. 5.4  2.3% vs. 8.8  1.9% (p  0.01 vs. VA at 6 AM); control subjects:
9.5  2.8% vs. 9.0  2.2% vs. 9.9  1.9%, respectively). The frequency of spontaneous
ischemic episodes was highest from midnight to morning and was lowest from morning to
late afternoon (4 PM to midnight: 7 episodes; midnight to 8 AM: 25 episodes; 8 AM to 4 PM:
3 episodes).
CONCLUSIONS There is diurnal fluctuation in endothelial function, which is associated with variation in the
frequency of ischemic episodes. (J Am Coll Cardiol 2002;40:266–70) © 2002 by the
American College of Cardiology Foundation
Spasm of an epicardial coronary artery (i.e., coronary spasm)
is well known to play an important role in the pathogenesis
of not only variant angina (VA) but also other forms of
angina pectoris and acute myocardial infarction (1,2). We,
as well as other investigators, have reported that coronary
spasm is induced by acetylcholine (ACh), which causes
vasodilation when the endothelium is functioning normally,
and the spasm is promptly relieved by nitroglycerin (NTG),
which causes vasodilation through its direct action on the
smooth muscle (3–6). This phenomenon suggests the pos-
sibility that patients with coronary spasm have a disturbance
in the endothelial function of their coronary arteries (7).
The frequency of ischemic attacks displays diurnal vari-
ation in patients with VA (i.e., coronary spastic angina).
The number of attacks increases in the early morning and
decreases in the afternoon (7,8). If endothelial function is
involved in the occurrence of coronary spasm, endothelial
function may also fluctuate according to this diurnal varia-
tion. Thus, the present study was designed to examine
whether there is diurnal fluctuation in the endothelial
function of patients with VA.
METHODS
The present study included 20 patients with VA (mean age
54.5 years [range 33 to 63 years]; 10 men and 10 postmeno-
pausal women) in whom recurrent attacks of chest symp-
toms occurred spontaneously at rest, with ST-segment
elevation on the electrocardiogram (ECG), that was rapidly
relieved by NTG. Coronary angiography was performed
before the study, using the Judkin’s technique. All patients
had proven coronary spasm as demonstrated by chest
symptoms and ST-segment elevation after intracoronary
injection of ACh (3,7,9). The study also included 20 control
subjects (mean age 54.2 years [range 32 to 62 years]; 10 men
and 10 postmenopausal women). These subjects were se-
lected to match the risk factors for atherosclerosis in the
patients with VA. The control subjects underwent diagnos-
tic cardiac catheterization for evaluation of chest symptoms.
None showed coronary spasm after the intracoronary injec-
tion of ACh. None had any organic coronary stenosis,
including irregularities of the lumen, by coronary angiogra-
phy. The patients’ characteristics are shown in Table 1. All
medications, except sublingual NTG, were discontinued
from at least seven days before study entry to completion of
the study. All subjects gave written, informed consent, and
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the study was approved by the ethics committee of our
institution.
Evaluation of myocardial ischemia. Myocardial ischemia
of VA is often asymptomatic (7). To evaluate the frequency
of both symptomatic and asymptomatic spontaneous isch-
emic episodes, all subjects had 24-h ambulatory ECG
monitoring (Nihon Kohden, Tokyo, Japan) at 4 PM. The
subjects were also instructed to record any symptoms during
the study. An ischemic episode was defined as a period of
ST-segment depression (horizontal or downsloping) of
0.1 mV or ST-segment elevation 0.2 mV, lasting
1 min before recovery to baseline, and was separated from
another episode by an interval of 2 min.
Vascular studies. Increased blood flow during reactive
hyperemia after transient occlusion causes vasodilation,
mainly by releasing endothelium-derived nitric oxide or its
related substances (10,11). Thus, endothelial function was
evaluated by flow-mediated, endothelium-dependent vaso-
dilation of the brachial arteries, using ultrasonography. The
validity of this method has been confirmed in our previous
studies and in other studies (12–15). The observation was
performed in the evening (8 PM), in the following early
morning (6 AM) and in the afternoon (2 PM), coincidentally
with 24-h ambulatory ECG monitoring. Subjects were
instructed to lie on a bed before and during the interval
between the observations, except for mealtime or rest room
necessity. Vasoactive substances, including beverages con-
taining caffeine, were withdrawn. All observations were
performed in a quiet, temperature-controlled room (22°C to
23°C) by two skillful examiners who had no knowledge of
the subjects’ grouping.
The brachial artery above the bifurcation, in the non-
dominant arm, was scanned in a longitudinal fashion, using
a 7.5-MHz linear-array transducer (SONOS 2500, Philips,
Amsterdam, The Netherlands). Optimal images were ob-
tained between 1 and 5 cm above the antecubital crease.
This location was marked, and all subsequent images were
obtained at the same location. To ensure that measurements
were taken at the same point of the brachial artery for the
three observations, the exact distance from the antecubital
crease to the mark was recorded for each patient. All
machine operating parameters, including depth and gain
settings, were optimized for each patient and were kept
constant throughout the three observations.
The subjects laid quietly for 10 min before the first scan.
After baseline measurements of the diameter and flow
velocity of the brachial arteries, a blood pressure cuff placed
around the forearm, below the bifurcation, was inflated to a
pressure of 250 to 300 mm Hg. After 5 min, the cuff was
released. Measurements of the diameter and flow velocity
were continuously performed between the cuff inflations and
after the cuff deflation. Thereafter, the subjects laid quietly
for 15 min. After confirming that the diameter and flow
velocity returned to baseline levels, sublingual NTG was
administered (0.3 mg), and 3 to 4 min later, the last
measurements were performed.
B-mode ultrasound images were recorded on a super-
VHS videocassette recorder (BR-S601M, Victor, Tokyo,
Japan). The diameter of the artery was measured at a fixed
distance from an anatomic marker, using ultrasonic calipers.
The measurements were taken from the anterior to posterior
“m” line (the interface between the media and adventitia) at
end diastole, coincident with the R-wave on a continuously
recorded ECG (12,14,15). The diameter at four cardiac
cycles was analyzed for each scan, and the measurements
were averaged. The diameter measurements for reactive
hyperemia were taken 45 to 90 s after the cuff deflation to
measure the peak diameter (12,14,15). The response of the
vessel diameter to reactive hyperemia and NTG was ex-
pressed as the percent increase in relation to the baseline
diameter value. Volumetric blood flow was calculated by
multiplying the velocity-time integral of the Doppler flow
signal by the heart rate and vessel cross-sectional area. The
percent increase in the blood flow of the brachial artery,
observed immediately after the cuff deflation, was calculated
as the maximal flow recorded within the first 15 s after the
cuff deflation divided by the flow at baseline (12–15).
In our study, the interobserver variability for the repeated
measurements of the arterial diameter at rest was 0.05 
0.02 mm. The intraobserver variability for the repeated
measurements of the arterial diameter at rest was 0.02 
0.02 mm. In a preliminary study, when these procedures
were performed at the same time on two separate days in 20
volunteers, the average intrasubject test-retest difference for
the measurements of the arterial diameter during reactive
hyperemia was 0.05  0.04 mm (12,14).
Blood sampling and assays. Blood samples were obtained
from the subjects while they were in the fasting state, before
the ultrasound studies. Serum total cholesterol and triglyc-
eride concentrations were measured enzymatically, and the
Abbreviations and Acronyms
ACh  acetylcholine
ANOVA  analysis of variance
ECG  electrocardiogram/electrocardiographic
NTG  nitroglycerin
VA  variant angina
Table 1. Patient Characteristics
Control Subjects
(n  20)
Patients With
Variant Angina
(n  20)
p
Value
Age (yrs) 54.2  9.8 54.5  8.8 NS
Men/women 10/10 10/10
Smoker 9 (47.4%) 9 (47.4%) NS
Hypertension 3 (15.8%) 3 (15.8%) NS
Total cholesterol (mg/dl) 199.8  14.4 197.9  15.8 NS
HDL cholesterol (mg/dl) 52.0  6.2 51.7  5.8 NS
LDL cholesterol (mg/dl) 123.0  10.2 122.7  11.8 NS
Triglyceride (mg/dl) 110.0  10.4 109.0  9.8 NS
Data are expressed as the mean value  SD.
HDL  high-density lipoprotein; LDL  low-density lipoprotein.
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serum high-density lipoprotein cholesterol concentration
was measured by heparin-Ca2/Ni2 precipitation (14,16).
Statistical analysis. The characteristics of the patients were
compared using the two-tailed, unpaired t test for contin-
uous data and the chi-square test for group data. Analysis of
variance (ANOVA) was used to compare the values of the
myocardial ischemic episodes. When statistically significant
effects were found, the Newman-Keuls test was used to
isolate the differences between the groups. Two-way
ANOVA with repeated measures, followed by post-hoc
testing with the Scheffe´’s test, was used to compare the
values of the ultrasound studies between the two groups.
Correlation between flow-mediated vasodilation and myo-
cardial ischemic episodes was made using linear regression
analysis. Statistical significance was set at p 0.05. Data are
expressed as the mean value SD.
RESULTS
The baseline variables are shown in Table 2. The baseline
values of heart rate (p  0.02) and brachial blood flow (p 
0.01) were greater in the evening and afternoon than in the
early morning in both the patients with VA and the control
subjects. The baseline values of mean blood pressure were
comparable among the three studies in both groups. Al-
though the baseline diameter tended to be greater in the
evening and afternoon than in the early morning, the
differences were not significant in either group.
Every patient with VA had chest symptoms with ST-
segment elevation during 24-h ambulatory ECG monitor-
ing. Figure 1 shows the diurnal variation of the total and
mean ischemic episodes in all 20 patients. The frequency of
ischemic episodes was highest from midnight to morning
(midnight to 8 AM: total 25 episodes, mean 1.3  0.6
episodes) and was lowest from morning to late afternoon
(8 AM to 4 PM: total 3 episodes, mean 0.2  0.4 episodes).
The frequency from late afternoon to midnight was higher
than that from morning to late afternoon (4 PM to midnight:
total 7 episodes, mean 0.4  0.7 episodes).
In patients with VA, flow-mediated vasodilation was
lowest in the early morning and was highest in the after-
noon. Flow-mediated vasodilation in the evening tended to
be lower than that in the afternoon (8 PM: 7.8  2.1% [p 
0.01 vs. 6 AM value]; 6 AM: 5.4  2.3%; 2 PM: 8.8  1.9%
[p  0.01 vs. 6 AM value]). The control subjects showed a
similar pattern, but the difference was not significant (8 PM:
9.5  2.8%; 6 AM: 9.0  2.2%; 2 PM: 9.9  1.9%). Between
Table 2. Hemodynamic Parameters
Control Subjects (n  20) Patients With Variant Angina (n  20)
Evening
(8 PM)
Early Morning
(6 AM)
Afternoon
(2 PM)
Evening
(8 PM)
Early Morning
(6 AM)
Afternoon
(2 PM)
Heart rate (beats/min) 65.1  10.9* 58.8  10.0 66.1  9.9* 64.7  9.1† 57.7  8.0 65.8  10.0†
Mean blood pressure (mm Hg) 93.8  6.7 92.8  7.7 93.9  5.0 90.1  7.9 91.4  9.4 91.1  6.8
Baseline diameter (mm) 3.70  0.19 3.67  0.16 3.72  0.15 3.69  0.15 3.59  0.18 3.68  0.14
Baseline flow (ml/min) 222.4  20.9‡ 168.5  16.8 232.4  23.2‡ 204.8  24.1§ 159.3  15.6 210.8  25.7§
Increase in flow during reactive hyperemia (%) 271.3  20.4 289.4  28.1 260.3  26.9 255.3  25.7 257.3  25.4 240.3  24.3
Increase in diameter after nitroglycerin (%) 17.0  3.8 17.8  5.6 16.8  3.0 17.0  4.7 18.1  5.1 17.9  3.7
*p  0.02 vs. early morning (6 AM) in control subjects. †p  0.02 vs. early morning (6 AM) in patients with variant angina. ‡p  0.01 vs. early morning (6 AM) in control subjects.
§p  0.01 vs. early morning (6 AM) in patients with variant angina. Data are expressed as the mean value  SD.
Figure 1. Diurnal variation of the total myocardial ischemic episodes in all patients with variant angina (A) and that of the mean myocardial ischemic
episodes in each patient (B). The frequency of ischemic episodes was highest from midnight to morning (00:00 to 08:00) and was lowest from morning
to late afternoon (08:00 to 16:00). The frequency from late afternoon to midnight was higher than that from morning to late afternoon (16:00 to 00:00).
*p  0.01 vs. from midnight to morning (00:00 to 08:00). See text for details. 00:00  midnight; 08:00  8 AM; 16:00  4 PM.
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the two groups, flow-mediated vasodilation was comparable
in the evening (7.8  2.1% vs. 9.5  2.8%; p  NS) and in
the afternoon (8.8 1.9% vs. 9.9 1.9%; pNS), but was
less in the patients with VA in the early morning (5.4 
2.3% vs. 9.0  2.2%; p  0.01). The fluctuation in
flow-mediated vasodilation was significantly different be-
tween the two groups (p  0.01 by ANOVA), as shown in
Figure 2. There was a negative correlation between flow-
mediated vasodilation and the frequency of myocardial
ischemic episodes (Fig. 3). Nitroglycerin-induced vasodila-
tion (endothelium-independent vasodilation) remained un-
changed throughout the three observations and was com-
parable between the two groups, as shown in Table 2.
DISCUSSION
In the present study, the frequency of ischemic episodes
displayed diurnal variation in patients with VA, which is
consistent with the results of our previous studies (2,7).
Endothelial function of the brachial artery fluctuated in
association with the frequency of ischemic episodes.
Mechanism(s) of coronary spasm. The precise mechanism
of coronary spasm is still unknown. There has been consid-
erable debate regarding whether endothelial function is
impaired or preserved at the site of coronary spasm (2–
4,7,17–19). However, endothelium-dependent vasodilation,
which plays a crucial role in the regulation of vessel tone, is
known to be induced in response to various stimuli, includ-
ing ACh, serotonin, ergonovine, histamine, blood flow and
shear stress (20–22). In patients with coronary spasm,
coronary dilation caused by these endothelium-dependent
vasodilators is reported to be impaired (3–7,23). In addition,
antioxidants, such as vitamin C and glutathione, attenuate
the constrictor response to ACh (24,25). The plasma levels
of vitamin E, a natural antioxidant, are decreased (26), and
its oral administration reduces the myocardial ischemic
episodes due to coronary spasm and improves the
endothelium-dependent vasodilation of brachial arteries in
patients with coronary spasm (12). In the present study,
intracoronary injection of ACh caused coronary spasm in all
patients with VA. Thus, patients with coronary spasm may
have a disturbance in endothelial function of the coronary
arteries, as well as a hypercontractile response of vascular
smooth muscle (7).
We have further reported that the coronary arteries of
patients with VA exhibit a circadian variation in tone (8),
similar to the phenomenon observed in the present study.
As the endothelial function of the brachial artery and that of
the coronary artery are closely related (12), the fluctuation of
endothelium-dependent dilation in the brachial artery most
likely takes place in the coronary arteries as well.
Mechanism(s) of diurnal variation in flow-mediated va-
sodilation. The precise mechanism of this fluctuation re-
mains undetermined in the present study. However, it is
known that the day/night pattern in the intensity of physical
activity causes diurnal variation of hemodynamics (27). In
the evening and afternoon, peripheral blood flow to the
skeletal muscle is increased through local regulation in
proportion to its need for oxygen and nutrients (28).
Likewise, in the present study, the baseline values of
brachial artery blood flow were greater in the evening and
afternoon than in the early morning in both groups.
Endothelial nitric oxide synthase is known to be upregu-
lated by increased blood flow or shear stress (29–31).
Therefore, it is possible that the variation in baseline blood
flow may upregulate nitric oxide synthase and contribute to
the fluctuation of the flow-mediated, endothelium-
dependent vasodilation in patients with VA. Diurnal fluc-
tuation of endothelial function may play an important role
in the occurrence of ischemic episodes in patients with VA.
In contrast, the endothelium-dependent vasodilation of
the brachial artery in the control subjects also showed a
similar pattern, but the difference was not significant in the
present study. This may be supported by the finding that
coronary segments with dysfunctional endothelium dis-
played morning exaggeration in their constrictor response to
Figure 2. Fluctuation of flow-mediated, endothelium-dependent vasodi-
lation in 20 patients with variant angina (solid circles) and 20 control
subjects (open circles). See text for details. *p  0.01 by analysis of
variance. 06:00  6 AM; 14:00  2 PM; 20:00  8 PM.
Figure 3. Relationship between flow-mediated, endothelium-dependent
vasodilation and the frequency of ischemic episodes. See text for details.
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ACh, whereas segments with normally functioning endo-
thelium showed no such variation (32).
The present study demonstrated for the first time, to the
best of our knowledge, that there is diurnal fluctuation in
the endothelial function of patients with VA, which is
associated with the frequency of ischemic attacks.
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